SFM
ARNA

Systematic Financial Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Systematic Financial Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,965
Closed -$419K – 563
2020
Q1 		$419K Sell
9,965
-2,930
-23% -$134K 0.03% 205
2019
Q4 		$586K Buy
12,895
+1,305
+11% +$61.7K 0.02% 374
2019
Q3 		$530K Sell
11,590
-4,045
-26% -$227K 0.02% 363
2019
Q2 		$917K Buy
+15,635
New +$808K 0.04% 368

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Systematic Financial Management's ARNA Position: Q2 2020 in Review

Systematic Financial Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 9,965 shares — an estimated $419K sold.

Systematic Financial Management first reported a position in ARNA in Q2 2019 and held it in 4 quarters. The position peaked at $917K in Q2 2019. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

  • Systematic Financial Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Systematic Financial Management sold 9,965 Arena Pharmaceuticals Inc shares in Q2 2020, an estimated $419K.
  • Systematic Financial Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 4 quarters.
  • Systematic Financial Management's Arena Pharmaceuticals Inc position peaked at $917K in Q2 2019.
  • 247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Systematic Financial Management's 13F filing for Q2 2020, filed 13 Aug 2020.